Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Sees Significant Decrease in Short Interest

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a large drop in short interest in December. As of December 15th, there was short interest totalling 27,800 shares, a drop of 46.5% from the November 30th total of 52,000 shares. Based on an average trading volume of 276,600 shares, the days-to-cover ratio is currently 0.1 days.

Biodexa Pharmaceuticals Stock Down 8.7 %

Shares of NASDAQ BDRX traded down $0.41 during midday trading on Friday, reaching $4.29. The company’s stock had a trading volume of 18,151 shares, compared to its average volume of 144,341. The stock has a 50 day simple moving average of $5.05. Biodexa Pharmaceuticals has a fifty-two week low of $3.50 and a fifty-two week high of $74.00.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.